NCT06649955 - Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 10, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

November 30, 2026

Conditions

ALS - Amyotrophic Lateral Sclerosis

Interventions

DEVICE

Multi-site direct current stimulation (DCS)

The MyoRegulator® treatment is a non-invasive intervention that suppresses motor neuron hyperexcitability and activates protein degradation pathways through the use of multi-site direct current stimulation (multi-site DCS).

Trial Locations (1)

02215

RECRUITING

Beth Israel Deaconess Medical Center, Boston